🔎 Trials Near Me

Akèy › Dyabèt Tip 2 › Nebraska › Omaha

Etid klinik pou Dyabèt Tip 2 nan Omaha, NE

11 etid pou Dyabèt Tip 2 ap chèche patisipan nan sit nan ak bò kote Omaha (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Ap rekriteFaz 3
  • Quality Clinical Research - Omaha, Omaha
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Ap rekriteFaz 3
  • University Of Nebraska Medical Center, Omaha
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07595549

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Ap rekriteFaz 3
  • Research Site, Omaha
  • Research Site, Omaha
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07784270

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

Ap rekriteFaz 2
  • University of Nebraska Medical Center, Omaha
Laj 18 a 80 · Tout sèks · Mizajou Sep 11, 2026 · NCT07271186

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Ap rekriteFaz 2
  • Velocity Clinical Research, Omaha, Omaha
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07296484

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

Ap rekriteFaz 3
  • Research Site, Elkhorn · 17 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT07662109

Blood Markers of Early Pancreas Cancer

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Unversity of Nebraska Medical Center, Omaha
Laj 19 ak plis · Tout sèks · Mizajou Feb 2, 2026 · NCT03568630

SCS for Patient With Painful Diabetic Neuropathy and Peripheral Arterial Disease

Ap rekrite
  • University of Nebraska Medical Center, Omaha
Laj 19 a 89 · Tout sèks · Mizajou Oct 22, 2025 · NCT06480786

Etid Dyabèt Tip 2 nan lòt vil

Lòt etid nan Omaha

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.